Skip to main content
. 2019 Jan 25;42(8):931–940. doi: 10.1007/s40618-019-1005-6

Table 1.

Characteristics of adenoma tissue samples

Clinical diagnosis Sex Age Immunhistochemistry for anterior lobe hormones Tumor size based on preoperative MRI (mm3) Ki-67 proliferation index (%)
GH producing F 43 GH 1–3
GH producing M 49 GH < 1
GH producing M 51 GH, PRL < 3
GH producing M 22 GH, PRL 11,571 3
GH producing M 32 GH, PRL 3–4
GH producing F 49 GH, PRL 2652 3–4
GH producing F 22 GH, PRL 4–5
GH producing M 35 GH, PRL 6
GH producing M 30 GH, PRL 4840.495 8
GH producing F 48 GH, PRL 10
GH producing F 35 GH, PRL 5–6
GH producing F 60 GH, PRL < 3
NFPA F 39 FSH 1–2
NFPA M 51 FSH 15,488 2–3
NFPA M 44 FSH 2–3
NFPA F 76 FSH 3825 2–3
NFPA M 38 FSH 3–4
NFPA F 72 FSH, LH 1–2
NFPA M 63 FSH, LH 41,055 < 1
NFPA F 49 FSH, LH 3744 < 1
NFPA M 62 FSH, LH < 3
NFPA M 67 FSH, LH 3–4
NFPA M 43 FSH, LH 7–10
NFPA M 64 FSH, LH 126,000 < 3
NFPA F 74 FSH, LH < 3
NFPA F 73 FSH, LH 12,000 < 2
NFPA F 68 FSH, LH 3–4
NFPA M 73 FSH, LH 2–3
NFPA F 80 FSH, LH 19,600 2–3
NFPA F 69 FSH, LH 20,240 < 3
NFPA M 38 FSH, LH 3–4
NFPA F 37 FSH, LH 1872 7–8
NFPA M 73 LH 13,500 2
NFPA M 72 LH 4590 < 2
NFPA F 43 Negative 4987.5 1
NFPA F 50 Negative 2
NFPA F 64 Negative 1
NFPA F 58 Negative 3570 4
NFPA M 73 Negative 12,144 3–4
NFPA F 64 Negative 5
NFPA M 58 Negative 35,640 5–7
NFPA M 50 Negative < 2
NFPA F 49 Negative 3–4
NFPA F 65 Negative 2523.312 3–4
NFPA F 60 Negative 5